A pharmaceutical company has made its first successful shipment of cannabis-based medicine, NanaBis.

The drug will be used for advanced cancer pain at Royal North Shore Hospital in Sydney as part of a clinical trial.

Medlab CEO Sean Hall tells Ross Greenwood it’s “more than plausible”.

He says he’s hoping to provide an alternative to opioid use.

The trial holds a special significance for Mr Hall who lost his brother 10  years ago to cancer.

“One of the things I couldn’t fathom was the amount of pain he was going through.”

When establishing Medlab he made it clear one of the key focuses would be to developed a therapy for pain management.

Listen to the full interview below